» Articles » PMID: 29570976

Spatial Systems Lipidomics Reveals Nonalcoholic Fatty Liver Disease Heterogeneity

Overview
Journal Anal Chem
Specialty Chemistry
Date 2018 Mar 24
PMID 29570976
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular lipid accumulation characterizes nonalcoholic fatty liver disease (NAFLD). However, the types of lipids associated with disease progression are debated, as is the impact of their localization. Traditional lipidomics analysis using liver homogenates or plasma dilutes and averages lipid concentrations, and does not provide spatial information about lipid distribution. We aimed to characterize the distribution of specific lipid species related to NAFLD severity by performing label-free molecular analysis by mass spectrometry imaging (MSI). Fresh frozen liver biopsies from obese subjects undergoing bariatric surgery ( n = 23) with various degrees of NAFLD were cryosectioned and analyzed by matrix-assisted laser desorption/ionization (MALDI)-MSI. Molecular identification was verified by tandem MS. Tissue sections were histopathologically stained, annotated according to the Kleiner classification, and coregistered with the MSI data set. Lipid pathway analysis was performed and linked to local proteome networks. Spatially resolved lipid profiles showed pronounced differences between nonsteatotic and steatotic tissues. Lipid identification and network analyses revealed phosphatidylinositols and arachidonic acid metabolism in nonsteatotic regions, whereas low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) metabolism was associated with steatotic tissue. Supervised and unsupervised discriminant analysis using lipid based classifiers outperformed simulated analysis of liver tissue homogenates in predicting steatosis severity. We conclude that lipid composition of steatotic and nonsteatotic tissue is highly distinct, implying that spatial context is important for understanding the mechanisms of lipid accumulation in NAFLD. MSI combined with principal component-linear discriminant analysis linking lipid and protein pathways represents a novel tool enabling detailed, comprehensive studies of the heterogeneity of NAFLD.

Citing Articles

A Comprehensive Analysis of Liver Lipidomics Signature in Adults with Metabolic Dysfunction-Associated Steatohepatitis-A Pilot Study.

Mouskeftara T, Kalopitas G, Liapikos T, Arvanitakis K, Theocharidou E, Germanidis G Int J Mol Sci. 2024; 25(23).

PMID: 39684777 PMC: 11642547. DOI: 10.3390/ijms252313067.


Lipoprotein Lipidomics as a Frontier in Non-Alcoholic Fatty Liver Disease Biomarker Discovery.

Herrera-Marcos L, Arbones-Mainar J, Osada J Int J Mol Sci. 2024; 25(15).

PMID: 39125855 PMC: 11311740. DOI: 10.3390/ijms25158285.


Effect of High Energy Low Protein Diet on Lipid Metabolism and Inflammation in the Liver and Abdominal Adipose Tissue of Laying Hens.

Du X, Wang Y, Amevor F, Ning Z, Deng X, Wu Y Animals (Basel). 2024; 14(8).

PMID: 38672347 PMC: 11047412. DOI: 10.3390/ani14081199.


Lipidomic Analysis of Liver and Adipose Tissue in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice Model Reveals Alterations in Lipid Metabolism by Weight Loss and Aerobic Exercise.

Mouskeftara T, Deda O, Papadopoulos G, Chatzigeorgiou A, Gika H Molecules. 2024; 29(7).

PMID: 38611773 PMC: 11013466. DOI: 10.3390/molecules29071494.


Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation.

Peleman C, Francque S, Vanden Berghe T EBioMedicine. 2024; 102:105088.

PMID: 38537604 PMC: 11026979. DOI: 10.1016/j.ebiom.2024.105088.


References
1.
Gupta J, Gaikwad A, Tikoo K . Hepatic expression profiling shows involvement of PKC epsilon, DGK eta, Tnfaip, and Rho kinase in type 2 diabetic nephropathy rats. J Cell Biochem. 2010; 111(4):944-54. DOI: 10.1002/jcb.22783. View

2.
Than N, Newsome P . A concise review of non-alcoholic fatty liver disease. Atherosclerosis. 2015; 239(1):192-202. DOI: 10.1016/j.atherosclerosis.2015.01.001. View

3.
Strasberg S, Howard T, Molmenti E, Hertl M . Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology. 1994; 20(4 Pt 1):829-38. DOI: 10.1002/hep.1840200410. View

4.
Garcia-Canaveras J, Donato M, Castell J, Lahoz A . A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations. J Proteome Res. 2011; 10(10):4825-34. DOI: 10.1021/pr200629p. View

5.
Habenicht A, Salbach P, Goerig M, Zeh W, Blattner C, KING W . The LDL receptor pathway delivers arachidonic acid for eicosanoid formation in cells stimulated by platelet-derived growth factor. Nature. 1990; 345(6276):634-6. DOI: 10.1038/345634a0. View